Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
FOXO Technologies logo — Bringing epigenetic technology and artificial intelligence t...

FOXO Technologies

Bringing epigenetic technology and artificial intelligence to life.

Founded 2016 United States Minneapolis, United States 3 employees Post-IPO Debt Total: $65.30M Biotechnology, Health Care +1

General Information

Company Name FOXO Technologies
Founded Year 2016
Location United States Minneapolis, United States
Founders / Decision Makers
Team member
Employees 3
Industries Biotechnology, Health Care, Clean Energy
Funding Stage Post-IPO Debt
Business Model B2B, B2B2C, SaaS
Revenue Model Subscription, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with FOXO Technologies. To contact FOXO Technologies, visit foxotechnologies.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does FOXO Technologies compare?

A PDF of FOXO Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting FOXO Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About FOXO Technologies

FOXO Technologies, founded in 2016, is revolutionizing the global longevity insurance industry. With a compelling slogan, "Bringing epigenetic technology and artificial intelligence to life," the company leverages advanced epigenetic technology and artificial intelligence to transform underwriting protocols and enhance consumer engagement.

The company's innovations target the measurement of health and aging states through epigenetic biomarkers, positioning FOXO Technologies at the intersection of Biotechnology, Health Care, and Clean Energy sectors. Headquartered in the United States, FOXO's strategic initiatives cater to the growing demand for personalized health solutions and longevity assurance.

Most recently, the company secured a $2.80M post-IPO debt investment on June 18, 2024. As an emerging leader, FOXO's unique fusion of biotechnology and AI merits consideration from investors seeking innovation in health technology.

Business keywords: epigenetic technology, longevity insurance, underwriting protocol, consumer engagement platform, supervised machine learning, biomarkers, health, aging, technology, insights, startup, investor

Services & Products

Epigenetic diagnostics and interpretation
Operation of rural hospitals
Operation of mental and behavioral health facilities

Target Customers

Healthcare providers Mental health patients Rural communities Investors in healthcare sector

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $2.80M -
18 Jun 2024
Series C $22.50M 1
The Gray Insurance Company
24 Feb 2022
Series B $10.00M 2
Centrecourt Asset Management
Centrecourt Asset Management, Bespoke Growth Partners
07 Apr 2021
Series A $30.00M -
11 Nov 2019

FOXO Technologies Alternatives & Competitors

FOXO Technologies vs
AVESTHAGEN LIMITED
AVESTHAGEN LIMITED India

BRINGING SCIENCE TO LIFE - Convergence of Food Pharma & Population Genetics

Venture round
109 employees
Biotechnology, Health Care
FOXO Technologies vs
Exai Bio
Exai Bio United States

Delivering next-generation liquid biopsy platform for the earliest detection and most accurate cance...

22 employees
Biotechnology, Health Care

FAQ About FOXO Technologies

Bringing epigenetic technology and artificial intelligence to life.
FOXO Technologies was founded in 2016.
FOXO Technologies is headquartered in Minneapolis, United States.
FOXO Technologies operates in Biotechnology, Health Care and Clean Energy. Its work centres on epigenetic technology, longevity insurance, underwriting protocol and consumer engagement platform. Its customers include Healthcare providers, Mental health patients and Rural communities.
FOXO Technologies has a B2B, B2B2C and SaaS business model. Its revenue comes from Subscription, Service Fee and Licensing.
FOXO Technologies has approximately 3 employees.
FOXO Technologies has completed 4 funding rounds, raising a total of $65.30M. The latest funding stage is Post-IPO Debt.
FOXO Technologies offers: Epigenetic diagnostics and interpretation, Operation of rural hospitals, Operation of mental and behavioral health facilities.
Top alternatives and competitors to FOXO Technologies include AVESTHAGEN LIMITED, Exai Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
FOXO Technologies and AVESTHAGEN LIMITED are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for FOXO Technologies, https://bouncewatch.com/company/foxo-technologies, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout